Aclaris Therapeutics ACRS Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue$1.8MBeat by $639.5K
EPS-$0.13In line
Revenue estimate$1.1M
EPS estimate-$0.13
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$1.4M
EPS estimate-$0.16
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Ask the moment Aclaris Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aclaris Therapeutics report Q2 2025 earnings?
- Aclaris Therapeutics (ACRS) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Aclaris Therapeutics's Q2 2025 revenue and EPS?
- Aclaris Therapeutics reported revenue of $1.8M and eps of $-0.13 for Q2 2025.
- Did Aclaris Therapeutics beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $1.1M by $639.5K. EPS beat the consensus estimate of $-0.13 by $0.00.
- How did Aclaris Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 35.8% from $2.8M a year earlier and eps grew 13.3% from $-0.15.
- Where can I find Aclaris Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-010789) directly on SEC EDGAR. The filing index links above go to sec.gov.